Case Report Reveals Another Possible Side Effect of Kratom
According to the authors, this is the first report of kratom-induced hyperprolactinemia.
Hypogonadism
Endocrine Society Updates Testosterone Therapy Guidelines
Men should only be diagnosed with hypogonadism, says the new guideline, if they display symptoms of a testosterone deficiency and their measurements of total or free testosterone are unequivocally and consistently low.
FDA Committee Votes on New Oral Testosterone Replacement Tx
The FDA’s Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) voted 6 in favor and 13 against the benefit/risk profile of Tlando (testosterone undecanoate) capsules.
Ibuprofen Use Linked to Compensated Hypogonadism in Males
For short term ibuprofen use the effects of compensated hypogonadism are reversible, however the researchers state how it is unknown whether these effects are reversible for long-term ibuprofen use.
AAP Releases New List of ‘Choosing Wisely’ Recommendations
The AAP Section for Endocrinology compiled a list of tests that parents and physicians should question.
Testosterone Replacement Therapy Discontinued
The discontinuation is not due to the safety or efficacy of the drug but due to the the multiple manufacturers that currently provide supply to the U.S. market.
Perrigo Launches Generic Axiron Topical Solution
Endogenous androgens, including testosterone and dihydrotestosterone (DHT), are responsible for the normal growth and development of male sex organs and for the maintenance of secondary sex characteristics.
Testosterone Rx Behaviors Examined at Different Levels of Healthcare
“Our results highlight the opportunity to intervene both at the provider and the site level to improve testosterone prescribing,” the authors write.
Metabolic Outcomes in Trans Teens Receiving Cross-Sex Hormones
The researchers found that of the 72 subjects taking testosterone, at each visit significant increases in hemoglobin/hematocrit levels and BMI were recorded, as was a decrease in high-density lipoprotein level.
Perrigo Approved for Generic Axiron Solution
Perrigo has received final approval from the Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Testosterone Topical Solution, the generic version of Eli Lilly’s Axiron Topical Solution.
